Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
CytoSite Biopharma
AddedFeb 15, 2024
UpdatedJun 18, 2026
CytoSite Biopharma

CytoSite Biopharma

Seed

CytoSite Biopharma: Innovating PET imaging probes for precise Immuno-Oncology therapy response prediction.

HQ
Sudbury, MA, US
Founded
2016
Overview
Compare
Fundraising
Employees

CytoSite Biopharma is a biotechnology startup focused on developing innovative PET imaging probes to predict and monitor responses to Immuno-Oncology (I-O) therapy. Founded by James Jenson in 2016 and based in Sudbury, Massachusetts, the company offers a proprietary small molecule PET imaging probe that helps clinicians identify early in the treatment cycle which patients will respond to I-O therapy.

CytoSite Biopharma has made significant strides in the field of medical imaging and cancer treatment. Their novel technology has the potential to enhance personalized medicine by improving the accuracy of treatment predictions, thus optimizing patient outcomes. The company's impact is marked by its contribution to more effective and tailored cancer therapies.

CytoSite Biopharma - Similar Companies

CytoAgents logo

CytoAgents

cytoagents.com

CytoLogic logo

CytoLogic

Camino Pharma logo

Camino Pharma

caminopharma.com

Sabik Medical logo

Sabik Medical

OncoResponse logo

OncoResponse

Immunophotonics logo

Immunophotonics

Cellens logo

Cellens

cellensinc.com

Predictive Biosciences logo

Predictive Biosciences

Umoja Biopharma logo

Umoja Biopharma

Aktis Oncology logo

Aktis Oncology

aktisoncology.com

LumaCyte logo

LumaCyte

lumacyte.com

MaveriX Oncology logo

MaveriX Oncology

Episteme Prognostics logo

Episteme Prognostics

epistemedx.com

Cyto Wave Technologies logo

Cyto Wave Technologies

PineTree Therapeutics logo

PineTree Therapeutics

pinetreetx.com

CytoSite Biopharma - Quick Facts

Who are CytoSite Biopharma's competitors?

Companies similar to CytoSite Biopharma include CytoAgents, CytoLogic, Camino Pharma and Sabik Medical.

When was CytoSite Biopharma founded?

CytoSite Biopharma was founded in 2016.

Where is CytoSite Biopharma's headquarters located?

CytoSite Biopharma's headquarters is located in Sudbury, MA, US.

When was CytoSite Biopharma's last funding round?

CytoSite Biopharma's most recent funding round was for $3M (USD) in September 2019.

How much has CytoSite Biopharma raised to-date?

As of Sep 10, 2019, CytoSite Biopharma has raised a total of $7.5M (USD).

How many employees does CytoSite Biopharma have?

CytoSite Biopharma has 6 employees as of Feb 5, 2024.

CytoSite Biopharma - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Cancer Diagnostics
  • PET Imaging
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research